Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.61 USD | +1.57% | -7.49% | +34.84% |
Dec. 03 | Stephens Upgrades Alignment Healthcare to Overweight From Equalweight, Price Target is $17 | MT |
Nov. 15 | Sector Update: Health Care Stocks Decline Premarket Friday | MT |
Capitalization | 2.23B 2.12B 1.96B 1.75B 3.15B 189B 3.49B 24.44B 9.02B 77.55B 8.36B 8.18B 338B | P/E ratio 2024 * |
-17x | P/E ratio 2025 * | -23.1x |
---|---|---|---|---|---|
Enterprise value | 2.12B 2.02B 1.87B 1.66B 3B 180B 3.33B 23.29B 8.6B 73.9B 7.96B 7.79B 322B | EV / Sales 2024 * |
0.79x | EV / Sales 2025 * | 0.6x |
Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Alignment Healthcare, Inc.
1 day | +1.57% | ||
1 week | -7.49% | ||
Current month | -7.93% | ||
1 month | -15.07% | ||
3 months | +29.00% | ||
6 months | +38.71% | ||
Current year | +34.84% |
Director | Title | Age | Since |
---|---|---|---|
John Kao
CEO | Chief Executive Officer | 62 | 2013-12-31 |
Thomas Freeman
DFI | Director of Finance/CFO | 35 | 2016-12-31 |
Chief Operating Officer | 43 | 2024-01-08 |
Manager | Title | Age | Since |
---|---|---|---|
John Kao
BRD | Director/Board Member | 62 | 2013-12-31 |
David Hodgson
BRD | Director/Board Member | 67 | 2013-12-31 |
Mark McClellan
BRD | Director/Board Member | 60 | 2013-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 1,439 M€ | +18.68% | - | |
0.03% | 287 M€ | +20.11% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.57% | -7.49% | +45.12% | -15.56% | 2.23B | ||
+0.82% | -6.62% | +2.80% | +18.18% | 520B | ||
-1.47% | -4.46% | -18.43% | -9.55% | 90.42B | ||
-2.44% | -7.03% | +20.31% | +44.86% | 86.61B | ||
-0.15% | -1.82% | -40.65% | -38.03% | 34.42B | ||
-3.04% | -4.54% | -23.13% | -27.71% | 28.63B | ||
-2.72% | -4.39% | -18.90% | -1.57% | 17.06B | ||
-3.94% | -6.76% | +233.61% | -28.28% | 1.59B | ||
-0.63% | +5.99% | -56.59% | -66.37% | 1.34B | ||
-0.12% | +5.01% | - | - | 511M | ||
Average | -1.27% | -3.44% | +16.02% | -13.78% | 78.29B | |
Weighted average by Cap. | -0.48% | -6.88% | -0.56% | +13.01% |
2024 * | 2025 * | |
---|---|---|
Net sales | 2.68B 2.55B 2.36B 2.1B 3.79B 227B 4.2B 29.4B 10.85B 93.29B 10.05B 9.83B 407B | 3.45B 3.28B 3.04B 2.7B 4.88B 292B 5.41B 37.86B 13.97B 120B 12.94B 12.66B 524B |
Net income | -130M -124M -115M -102M -185M -11.07B -205M -1.43B -529M -4.55B -490M -479M -19.84B | -94.93M -90.35M -83.73M -74.47M -134M -8.06B -149M -1.04B -385M -3.31B -356M -349M -14.44B |
Net Debt | -105M -99.78M -92.47M -82.25M -148M -8.9B -165M -1.15B -425M -3.65B -394M -385M -15.94B | -143M -136M -126M -112M -202M -12.12B -224M -1.57B -579M -4.98B -536M -524M -21.71B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-10 | 11.61 $ | +1.57% | 2,037,097 |
24-12-09 | 11.43 $ | +0.35% | 1,904,643 |
24-12-06 | 11.39 $ | -6.64% | 1,863,404 |
24-12-05 | 12.20 $ | -2.56% | 1,253,051 |
24-12-04 | 12.52 $ | -0.24% | 2,360,291 |
Delayed Quote Nasdaq, December 10, 2024 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALHC Stock